MEDNET 2007 - 12th World Congress on Internet in Medicine

MEDNET is a scientific conference organized under the auspices of the Society for the Internet in Medicine (SIM). MEDNET 2007 will be hosted by the Center for Healthcare Management at Germany's No. 1 listed Business School Leipzig Graduate School of Management (HHL).

The official journal is the Journal of Medical Internet Research (JMIR), the leading Open Acesss eHealth journal - www.jmir.org.

Besides the focus points "Economics of Internet & Medicine Applications" and "EHR and the electronic Health Card" MEDNET 2007 will have - as every year - many topics around Internet & Medicine.

MEDNET 2007 Tracks and Themes:

  • Putting electronic health records online
  • Open Source Initiatives in Internet & Healthcare
  • Integrated care & Workflow Management over the Internet
  • Patient Education and Information
  • Etrials: using the web and etechnologies for clinical trials
  • Public (e-)health, population health technologies, surveillance
  • Telemedicice and Heart Failure Management
  • Internet-based Management of Pace-Makers
  • Legal aspects of Internet and Medicine
  • Web-based medical education
  • Health communication on the internet
  • Online pharmacies
  • Internet publishing in medicine
  • Other topics

For further information, please visit:
www.mednet2007.com

Most Popular Now

SK bioscience and GSK start Phase 3 trial of adjuv…

SK bioscience (SK) and GlaxoSmithKline plc (GSK) today announced the initiation of a Phase 3 clinical study of SK's COVID-19 vaccine candidate, GBP510, in combination wit...

No serious health effects linked to mRNA COVID-19 …

Federal and Kaiser Permanente researchers combing the health records of 6.2 million patients found no serious health effects that could be linked to the 2 mRNA COVID-19 v...

Blood vessels produce growth factor that promotes …

Blood vessels supply tumors with nutrients and, on the other hand, enable cancer cells to spread throughout the body. The settlement of circulating tumor cells in a dista...

First-in-human clinical trial for a vaccine to tre…

The first patients have been enrolled in a phase 1 randomized placebo-controlled clinical trial to study a therapeutic vaccine for opioid use disorder developed by resear...

Sandoz strengthens pipeline by entering into agree…

Sandoz, a Novartis division, today announced that it has entered into a commercialization agreement with Bio-Thera Solutions, Ltd. for biosimilar bevacizumab (BAT1706). B...

Pfizer and BioNTech submit a variation to EMA with…

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced that they submitted a variation to the European Medicines Agency (EMA) requesting to update the Condition...

A drug costing less than €2 a day helps in the tre…

Metoprolol, a drug widely used to treat cardiovascular disease, is beneficial when administered to COVID-19patients. This is the finding of a study by investigators at th...

Rheumatoid arthritis treated with implanted cells …

With a goal of developing rheumatoid arthritis therapies with minimal side effects, researchers at Washington University School of Medicine in St. Louis have genetically ...

NIH scientists build a cellular blueprint of multi…

Chronic lesions with inflamed rims, or "smoldering" plaques, in the brains of people with multiple sclerosis (MS) have been linked to more aggressive and disabling forms ...

Scientific evidence to date on COVID-19 vaccine ef…

An expert review by an international group of scientists, including some at the WHO and FDA, concludes that, even for the delta variant, vaccine efficacy against severe C...

How a plant virus could protect and save your lung…

Using a virus that grows in black-eyed pea plants, nanoengineers at the University of California San Diego developed a new treatment that could keep metastatic cancers at...

COVID-19 nasal vaccine candidate effective at prev…

Breathe in, breathe out. That’s how easy it is for SARS-CoV-2, the virus that causes COVID-19, to enter your nose. And though remarkable progress has been made in develop...